Petmed Express Stock Analysis

PETS Stock  USD 4.63  0.07  1.49%   
PetMed Express is undervalued with Real Value of 7.2 and Target Price of 15.0. The main objective of PetMed Express stock analysis is to determine its intrinsic value, which is an estimate of what PetMed Express is worth, separate from its market price. There are two main types of PetMed Express' stock analysis: fundamental analysis and technical analysis.
The PetMed Express stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. PetMed Express is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. PetMed Stock trading window is adjusted to America/New York timezone.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

PetMed Stock Analysis Notes

About 48.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.99. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PetMed Express has Price/Earnings To Growth (PEG) ratio of 2.58. The entity recorded a loss per share of 0.06. The firm last dividend was issued on the 11th of August 2023. PetMed Express had 959692:319 split on the 4th of March 1999. PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida. Petmed Express operates under Pharmaceutical Retailers classification in the United States and is traded on NASDAQ Exchange. It employs 212 people. To find out more about PetMed Express contact Sandra Campos at 561 526 4444 or learn more at https://www.1800petmeds.com.

PetMed Express Quarterly Total Revenue

59.57 Million

PetMed Express Investment Alerts

PetMed Express is way too risky over 90 days horizon
PetMed Express appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 281.06 M. Net Loss for the year was (7.46 M) with profit before overhead, payroll, taxes, and interest of 78.08 M.
Latest headline from news.google.com: PetMed Express Why The Rebound Could Continue - Seeking Alpha

PetMed Express Upcoming and Recent Events

5th of February 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of May 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of March 2023
Last Financial Announcement
View

PetMed Largest EPS Surprises

Earnings surprises can significantly impact PetMed Express' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2005-10-24
2005-09-300.10.110.0110 
2004-10-25
2004-09-300.070.080.0114 
2004-05-17
2004-03-310.070.06-0.0114 
View All Earnings Estimates

PetMed Express Environmental, Social, and Governance (ESG) Scores

PetMed Express' ESG score is a quantitative measure that evaluates PetMed Express' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of PetMed Express' operations that may have significant financial implications and affect PetMed Express' stock price as well as guide investors towards more socially responsible investments.

PetMed Express Thematic Classifications

In addition to having PetMed Express stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Trump Equities Idea
Trump Equities
Companies that have responded positively to Trump presidency

PetMed Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Millennium Management Llc2024-06-30
316.1 K
Metavasi Capital Lp2024-09-30
229.1 K
Geode Capital Management, Llc2024-09-30
221.2 K
Dimensional Fund Advisors, Inc.2024-09-30
212.4 K
Charles Schwab Investment Management Inc2024-09-30
205.6 K
Two Sigma Advisers, Llc2024-06-30
183.2 K
Ameriprise Financial Inc2024-06-30
176.1 K
Invenomic Capital Management, Lp2024-09-30
172.7 K
Susquehanna International Group, Llp2024-06-30
157.7 K
Renaissance Technologies Corp2024-09-30
1.3 M
Hotchkis & Wiley Capital Management Llc2024-09-30
1.1 M
Note, although PetMed Express' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

PetMed Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 97.12 M.

PetMed Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.06)(0.05)
Return On Capital Employed(0.08)(0.08)
Return On Assets(0.04)(0.04)
Return On Equity(0.08)(0.07)

Management Efficiency

Return On Tangible Assets is likely to gain to -0.05 in 2024. Return On Capital Employed is likely to gain to -0.08 in 2024. At this time, PetMed Express' Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 5.5 M in 2024, whereas Total Current Assets are likely to drop slightly above 79 M in 2024. PetMed Express' management efficiency ratios could be used to measure how well PetMed Express manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 4.74  2.81 
Tangible Book Value Per Share 2.89  2.72 
Enterprise Value Over EBITDA(37.62)(35.74)
Price Book Value Ratio 0.99  0.94 
Enterprise Value Multiple(37.62)(35.74)
Price Fair Value 0.99  0.94 
Enterprise Value41.6 M39.5 M
Understanding the operational decisions made by PetMed Express management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Operating Margin
0.0144
Profit Margin
(0)
Beta
0.676
Return On Assets
(0.0009)
Return On Equity
(0.01)

Technical Drivers

As of the 1st of December, PetMed Express holds the Semi Deviation of 2.72, coefficient of variation of 729.42, and Risk Adjusted Performance of 0.1134. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PetMed Express, as well as the relationship between them. Please check PetMed Express jensen alpha and semi variance to decide if PetMed Express is priced some-what accurately, providing market reflects its current price of 4.63 per share. Given that PetMed Express has jensen alpha of 0.6552, we recommend you to check out PetMed Express's recent market performance to make sure the company can sustain itself at a future point.

PetMed Express Price Movement Analysis

java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. PetMed Express middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for PetMed Express. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

PetMed Express Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PetMed Express insiders, such as employees or executives, is commonly permitted as long as it does not rely on PetMed Express' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases PetMed Express insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

PetMed Express Outstanding Bonds

PetMed Express issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PetMed Express uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PetMed bonds can be classified according to their maturity, which is the date when PetMed Express has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

PetMed Express Predictive Daily Indicators

PetMed Express intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PetMed Express stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

PetMed Express Corporate Filings

13A
14th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
10Q
7th of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
6th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F3
18th of October 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
13A
10th of October 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
27th of September 2024
Other Reports
ViewVerify
F3
26th of September 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
12th of September 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

PetMed Express Forecast Models

PetMed Express' time-series forecasting models are one of many PetMed Express' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PetMed Express' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About PetMed Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how PetMed Express prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PetMed shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as PetMed Express. By using and applying PetMed Stock analysis, traders can create a robust methodology for identifying PetMed entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.02)(0.02)
Operating Profit Margin(0.03)(0.03)
Net Loss(0.03)(0.03)
Gross Profit Margin 0.28  0.39 

Current PetMed Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. PetMed analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. PetMed analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
15.0Hold2Odds
PetMed Express current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most PetMed analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand PetMed stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of PetMed Express, talking to its executives and customers, or listening to PetMed conference calls.
PetMed Analyst Advice Details

PetMed Stock Analysis Indicators

PetMed Express stock analysis indicators help investors evaluate how PetMed Express stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading PetMed Express shares will generate the highest return on investment. By understating and applying PetMed Express stock analysis, traders can identify PetMed Express position entry and exit signals to maximize returns.
Begin Period Cash Flow104.1 M
Total Stockholder Equity96.7 M
Capital Lease Obligations1.5 M
Property Plant And Equipment Net28.1 M
Cash And Short Term Investments55.3 M
Cash55.3 M
50 Day M A4.238
Net Interest Income511 K
Total Current Liabilities72.2 M
Forward Price Earnings17.9211
Investments-40.7 M
Interest ExpenseM
Stock Based Compensation6.9 M
Common Stock Shares Outstanding20.4 M
Tax Provision1.2 M
Quarterly Earnings Growth Y O Y2.667
Free Cash Flow-194 K
Other Current Assets6.5 M
Accounts Payable37 M
Net Debt-53.8 M
Other Operating Expenses289.2 M
Non Current Assets Total76.2 M
Liabilities And Stockholders Equity169.9 M
Non Currrent Assets Other5.9 M

Additional Tools for PetMed Stock Analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.